Infectious Diseases - Reviving reservoirs: new findings shake up HIV treatment understanding
Can't see this email? View it online
   
  Infectious Diseases  
  The latest infectious diseases news from News Medical  
 

Announcing our core reagents for HIV R&D!Announcing core reagents for HIV R&D!

The HIV-1 envelope glycoprotein (Env) is the most relevant target used to elicit an immune response against HIV. New research has highlighted the potential of using gp140 trimers for development that can eliminate non-neutralizing epitopes to be exposed. Explore ACRO's protein HIV antigens to help accelerate your research!

Optimize your HIV Research
 
   Reviving reservoirs: new findings shake up HIV treatment understandingReviving reservoirs: new findings shake up HIV treatment understanding
 
Researchers provide insight into the interaction between T lymphocytes and persisting reservoirs of HIV, with repercussions for harnessing effective, long-lasting responses to HIV eradication.
 
   Hepatitis C patients may benefit from revaccination against hepatitis B after treatmentHepatitis C patients may benefit from revaccination against hepatitis B after treatment
 
Recently published research from the University of Minnesota Medical School suggests individuals with hepatitis C should consider revaccination for hepatitis B. The study was published in the Journal of Infectious Diseases.
 
 Genomic Surveillance Finds Malaria-Causing Parasites Resistant to Treatments
 
Genomic Surveillance Finds Malaria-Causing Parasites Resistant to TreatmentsScientists have discovered new strains of malaria-causing parasites in Ethiopia that are both resistant to current treatments and evade detection by common diagnostic tests—a development that could increase malaria cases and deaths while making eradicating the disease even more difficult.
 
 
 Novel method using DNA nanoballs could revolutionize pathogen detection
 
Novel method using DNA nanoballs could revolutionize pathogen detectionResearchers at Karolinska Institute have developed a novel method using DNA Nanoballs to detect pathogens, aiming to simplify nucleic acid testing and revolutionize pathogen detection.
 
 
 Latest updates on SARS-CoV-2 variants identified in the UK
 
Latest updates on SARS-CoV-2 variants identified in the UKThe UK Health Security Agency (UKHSA) has published SARS-CoV-2 variant surveillance and assessment technical briefing 53. It contains the latest epidemiological and genomic analysis of the emergent BA.2.86 variant.
 
 
 Is the new bivalent COVID-19 vaccine the booster we've been waiting for?
 
Is the new bivalent COVID-19 vaccine the booster we've been waiting for?The bivalent COVID-19 vaccine developed by GSK and Sanofi shows promising results with a 64.7% overall effectiveness against symptomatic COVID-19, according to a phase 3 trial. The vaccine performs especially well as a booster, achieving 75.9% efficacy in non-naïve subjects.
 
 
 NIH launches Phase 1 trial of new investigational universal influenza vaccine
 
NIH launches Phase 1 trial of new investigational universal influenza vaccineEnrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health's Clinical Center in Bethesda, Maryland.
 
 

How would you rate today's newsletter?